Carl M. Gay

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Carl M. Gay, C. Allison Stewart, Elizabeth M. Park et al. · Cancer Cell · 2021 · 864 citations · Full text

Immunogenetics, Systems Biology, Distinct Therapeutic Vulnerabilities +11

Integrative Molecular Characterization of Malignant Pleural Mesothelioma

Julija Hmeljak, Francisco Sánchez-Vega, Katherine A. Hoadley et al. · Cancer Discovery · 2018 · 585 citations · Full text

CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade

Limo Chen, Lixia Diao, Yongbin Yang et al. · Cancer Discovery · 2018 · 457 citations

Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer

C. Allison Stewart, Carl M. Gay, Yuanxin Xi et al. · Nature Cancer · 2020 · 357 citations · Full text

Tumor Heterogeneity, Single-cell Analyses, Medicine +10

Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

Joshua D. Campbell, Christina Yau, Reanne Bowlby et al. · Cell Reports · 2018 · 352 citations · Full text